Profusa (NASDAQ:PFSA) Issues Quarterly Earnings Results

Profusa (NASDAQ:PFSA) released its quarterly earnings data on Friday. The company reported ($2.05) earnings per share (EPS) for the quarter, FiscalAI reports.

Profusa Price Performance

Shares of PFSA opened at $0.45 on Friday. The stock has a 50 day simple moving average of $0.70. Profusa has a fifty-two week low of $0.40 and a fifty-two week high of $180.00. The stock has a market cap of $1.96 million, a PE ratio of 0.00 and a beta of 0.47.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Wall Street Zen raised shares of Profusa from a “strong sell” rating to a “sell” rating in a research report on Saturday, April 18th. Weiss Ratings reissued a “sell (e+)” rating on shares of Profusa in a research report on Friday, March 27th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

About Profusa

Profusa develops implantable, tissue-integrated biosensors and associated reader technology designed to provide continuous, real-time monitoring of physiological biomarkers. Its platform uses a biocompatible, porous hydrogel sensor that is placed under the skin via a minimally invasive procedure and becomes perfused with tissue; an external optical reader interrogates the sensor to convert fluorescent or optical signals into quantitative measurements such as local tissue oxygen levels. The company’s approach emphasizes long-duration sensing from a single implanted device rather than repeated spot measurements.

The technology is being positioned to support a range of clinical and commercial applications, including chronic disease management, wound and post-surgical monitoring, and clinical research where continuous molecular-level data can improve decision-making.